Gonçalves Tiago Eduardo Dias, Zimmermann Glaucia Santos, Figueiredo Luciene Cristina, Souza Monique de Carvalho, da Cruz Daniele Ferreira, Bastos Marta Ferreira, da Silva Hélio Doyle Pereira, Duarte Poliana Mendes
Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil.
Department of Dentistry, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
J Clin Periodontol. 2015 May;42(5):431-9. doi: 10.1111/jcpe.12396. Epub 2015 Apr 30.
This study evaluated the effects of scaling and root planing (SRP) on gingival crevicular fluid (GCF) and serum levels of adipokines in patients with chronic periodontitis (CP) with or without obesity.
Twenty patients with obesity and 20 patients without obesity, all with CP, received SRP. Serum and GCF levels of resistin, adiponectin, leptin, tumour necrosis factor [TNF]-α and interleukin [IL]-6 were evaluated by enzyme-linked immunosorbent assay at baseline, 3, 6 and 12 months post-therapy.
SRP reduced the amounts of TNF-α in deep sites and increased the concentration of adiponectin in shallow sites of non-obese patients (p < 0.05). SRP increased the concentrations of TNF-α and leptin in patients with obesity (p < 0.05). GCF levels of TNF-α were higher in patients with obesity than in patients without obesity at all time-points (p < 0.05). There were no changes in serum levels of any adipokines for any group after therapy (p > 0.05). Patients with obesity exhibited higher serum levels of leptin at all time-points and IL-6 at 3 months post-therapy (p < 0.05).
Obesity may modulate systemic and periodontal levels of adipokines in favour of pro-inflammation, independently of periodontal therapy. SRP did not affect the circulating levels of adipokines in patients with or without obesity.
本研究评估了龈下刮治术(SRP)对伴有或不伴有肥胖的慢性牙周炎(CP)患者龈沟液(GCF)和血清中脂肪因子水平的影响。
20例肥胖患者和20例非肥胖患者,均患有CP,接受了SRP治疗。在治疗前基线、治疗后3个月、6个月和12个月,通过酶联免疫吸附测定法评估血清和GCF中抵抗素、脂联素、瘦素、肿瘤坏死因子(TNF)-α和白细胞介素(IL)-6的水平。
SRP降低了非肥胖患者深部位点的TNF-α含量,并增加了浅部位点的脂联素浓度(p<0.05)。SRP增加了肥胖患者TNF-α和瘦素的浓度(p<0.05)。在所有时间点,肥胖患者的GCF中TNF-α水平均高于非肥胖患者(p<0.05)。治疗后,任何组的血清中任何脂肪因子水平均无变化(p>0.05)。肥胖患者在所有时间点的血清瘦素水平均较高,治疗后3个月的IL-6水平较高(p<0.05)。
肥胖可能会调节全身和牙周组织中脂肪因子水平,有利于促炎反应,且与牙周治疗无关。SRP对伴有或不伴有肥胖的患者循环中脂肪因子水平没有影响。